A bivalent protein-based vaccine against respiratory syncytial virus (RSV) administered during pregnancy was safe and led to higher neutralizing antibody responses in mothers, as well as evidence of protection in their infants, an interim analysis of a ...
from Google Alert - health https://ift.tt/bkaBZSf
via IFTTT
0 comments:
Post a Comment